A Study to Investigate the Interaction Between TMP-301 and Cocaine.

Summary

This will be a randomized, double-blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of oral TMP-301, given concurrently with cocaine. The study will consist of 4 phases: Screening, Baseline, Treatment, and Follow-up.

Timeline

Start

2025-01-04

Primary completion

2025-05-05

Completion

2025-05-05

Drugs

Indications